相似文献
1
Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43.
J Infect Dis. 2005 Jun 15;191(12):2033-7. doi: 10.1086/430355. Epub 2005 May 6.
2
Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
J Infect Dis. 2021 Oct 28;224(8):1305-1315. doi: 10.1093/infdis/jiab333.
3
Antibody Mediated Immunity to SARS-CoV-2 and Human Coronaviruses: Multiplex Beads Assay and Volumetric Absorptive Microsampling to Generate Immune Repertoire Cartography.
Front Immunol. 2021 Jul 27;12:696370. doi: 10.3389/fimmu.2021.696370. eCollection 2021.
4
Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43.
J Vet Sci. 2010 Jun;11(2):165-7. doi: 10.4142/jvs.2010.11.2.165.
5
[Antigenicity analysis of nucleocapsid proteins of 3 human coronaviruses SARS-CoV, 229E and OC43 with their monoclonal antibodies].
Nan Fang Yi Ke Da Xue Xue Bao. 2006 Mar;26(3):290-3.
6
Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63.
Clin Diagn Lab Immunol. 2005 Nov;12(11):1317-21. doi: 10.1128/CDLI.12.11.1317-1321.2005.
7
Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study.
Emerg Microbes Infect. 2021 Dec;10(1):664-676. doi: 10.1080/22221751.2021.1905488.
8
Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults.
Clin Immunol. 2021 Aug;229:108782. doi: 10.1016/j.clim.2021.108782. Epub 2021 Jun 9.
9
Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
Transfusion. 2021 Feb;61(2):356-360. doi: 10.1111/trf.16161. Epub 2020 Oct 26.
10
Peptide microarray-based analysis of antibody responses to SARS-CoV-2 identifies unique epitopes with potential for diagnostic test development.
Eur J Immunol. 2021 Jul;51(7):1839-1849. doi: 10.1002/eji.202049101. Epub 2021 May 7.
引用本文的文献
1
Comprehensive analysis of human coronavirus antibody responses in ICU and non-ICU COVID-19 patients reveals IgG3 against SARS-CoV-2 spike protein as a key biomarker of disease severity.
J Med Microbiol. 2025 May;74(5). doi: 10.1099/jmm.0.002012.
2
SARS-CoV-2 Serological Investigation of White-Tailed Deer in Northeastern Ohio.
Viruses. 2023 Jul 22;15(7):1603. doi: 10.3390/v15071603.
3
SARS-CoV-2 seroprevalence among blood donors in Uganda: 2019-2022.
Transfusion. 2023 Jul;63(7):1354-1365. doi: 10.1111/trf.17449. Epub 2023 Jun 16.
4
Unravelling Antigenic Cross-Reactions toward the World of Coronaviruses: Extent of the Stability of Shared Epitopes and SARS-CoV-2 Anti-Spike Cross-Neutralizing Antibodies.
Pathogens. 2023 May 13;12(5):713. doi: 10.3390/pathogens12050713.
5
Cellular Immune Responses to SARS-CoV-2 in Exposed Seronegative Individuals.
Viruses. 2023 Apr 18;15(4):996. doi: 10.3390/v15040996.
6
Evaluating the Virology and Evolution of Seasonal Human Coronaviruses Associated with the Common Cold in the COVID-19 Era.
Microorganisms. 2023 Feb 10;11(2):445. doi: 10.3390/microorganisms11020445.
7
Recent advances in immunoassay technologies for the detection of human coronavirus infections.
Front Cell Infect Microbiol. 2023 Jan 4;12:1040248. doi: 10.3389/fcimb.2022.1040248. eCollection 2022.
8
Comparable diagnostic accuracy of SARS-CoV-2 Spike RBD and N-specific IgG tests to determine pre-vaccination nation-wide baseline seroprevalence in Mexico.
Sci Rep. 2022 Oct 26;12(1):18014. doi: 10.1038/s41598-022-22146-8.
9
Role of the humoral immune response during COVID-19: guilty or not guilty?
Mucosal Immunol. 2022 Jun;15(6):1170-1180. doi: 10.1038/s41385-022-00569-w. Epub 2022 Oct 4.
10
Laboratory and Point-of-Care Testing for COVID-19: A Review of Recent Developments.
Cureus. 2022 Aug 29;14(8):e28530. doi: 10.7759/cureus.28530. eCollection 2022 Aug.
本文引用的文献
1
Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in sars patients by enzyme-linked immunosorbent assay.
J Clin Microbiol. 2004 Jul;42(7):2884-9. doi: 10.1128/JCM.42.7.2884-2889.2004.
2
Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome.
J Clin Microbiol. 2004 Jun;42(6):2629-35. doi: 10.1128/JCM.42.6.2629-2635.2004.
3
Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA.
J Med Virol. 2004 Jul;73(3):338-46. doi: 10.1002/jmv.20096.
4
Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses: implication for SARS diagnosis.
J Clin Microbiol. 2004 May;42(5):2351-2. doi: 10.1128/JCM.42.5.2351-2352.2004.
5
Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia.
Lancet. 2004 Mar 13;363(9412):841-5. doi: 10.1016/S0140-6736(04)15729-2.
6
Detection of SARS coronavirus in patients with suspected SARS.
Emerg Infect Dis. 2004 Feb;10(2):294-9. doi: 10.3201/eid1002.030610.
7
Characterization of a novel coronavirus associated with severe acute respiratory syndrome.
Science. 2003 May 30;300(5624):1394-9. doi: 10.1126/science.1085952. Epub 2003 May 1.
8
Coronavirus as a possible cause of severe acute respiratory syndrome.
Lancet. 2003 Apr 19;361(9366):1319-25. doi: 10.1016/s0140-6736(03)13077-2.
9
A novel coronavirus associated with severe acute respiratory syndrome.
N Engl J Med. 2003 May 15;348(20):1953-66. doi: 10.1056/NEJMoa030781. Epub 2003 Apr 10.
10
Antigenic relationships among proteins of bovine coronavirus, human respiratory coronavirus OC43, and mouse hepatitis coronavirus A59.
J Virol. 1984 Aug;51(2):384-8. doi: 10.1128/JVI.51.2.384-388.1984.
Zotero 插件